Due to a production error, the incorrect Supplementary Material files were published. The Supplementary Material files have been corrected.
The publisher apologizes for this mistake. The original article has been updated.
Summary
Keywords
PLM, NCX1, disruptor peptide, NKA, cardiac, brain, peptide arrays, peptidomimetics
Citation
Frontiers Production Office (2021) Erratum: Design of a Proteolytically Stable Sodium-Calcium Exchanger 1 Activator Peptide for In Vivo Studies. Front. Pharmacol. 12:788046. doi: 10.3389/fphar.2021.788046
Received
01 October 2021
Accepted
01 October 2021
Published
21 October 2021
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2021
Updates
Copyright
© 2021 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, pharmacology.production.office@frontiersin.org
This article was submitted to Pharmacology of Ion Channels and Channelopathies, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.